Susanne E. Churchill, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 24 | 2019 | 4879 | 0.620 |
Why?
|
| Inflammatory Bowel Diseases | 12 | 2019 | 2442 | 0.480 |
Why?
|
| Personal Autonomy | 1 | 2016 | 315 | 0.440 |
Why?
|
| Colitis, Ulcerative | 8 | 2019 | 1926 | 0.410 |
Why?
|
| Crohn Disease | 8 | 2019 | 2294 | 0.400 |
Why?
|
| Natural Language Processing | 10 | 2019 | 1203 | 0.340 |
Why?
|
| Health Education | 1 | 2016 | 1059 | 0.330 |
Why?
|
| Algorithms | 16 | 2021 | 14201 | 0.320 |
Why?
|
| Information Storage and Retrieval | 6 | 2019 | 831 | 0.290 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 599 | 0.280 |
Why?
|
| Arthritis, Rheumatoid | 9 | 2015 | 3780 | 0.240 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 4045 | 0.210 |
Why?
|
| Antidepressive Agents | 5 | 2016 | 2913 | 0.200 |
Why?
|
| Vitamin D | 4 | 2015 | 3311 | 0.170 |
Why?
|
| Medical Record Linkage | 1 | 2021 | 286 | 0.170 |
Why?
|
| Depressive Disorder, Major | 5 | 2014 | 4818 | 0.150 |
Why?
|
| Depressive Disorder | 4 | 2016 | 3723 | 0.150 |
Why?
|
| Phenotype | 9 | 2019 | 16731 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 4356 | 0.130 |
Why?
|
| Clostridium Infections | 2 | 2014 | 562 | 0.130 |
Why?
|
| Autoantibodies | 3 | 2013 | 2120 | 0.120 |
Why?
|
| Hospitalization | 5 | 2014 | 10847 | 0.120 |
Why?
|
| Cohort Studies | 18 | 2016 | 41808 | 0.110 |
Why?
|
| Gastrointestinal Agents | 2 | 2016 | 510 | 0.110 |
Why?
|
| Suicide, Attempted | 1 | 2023 | 1409 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 942 | 0.110 |
Why?
|
| Vitamin D Deficiency | 2 | 2013 | 1388 | 0.110 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 236 | 0.100 |
Why?
|
| Pregnancy, Animal | 3 | 1982 | 124 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2016 | 2542 | 0.100 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2014 | 430 | 0.100 |
Why?
|
| Confidentiality | 2 | 2019 | 606 | 0.100 |
Why?
|
| Data Mining | 1 | 2017 | 563 | 0.100 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2014 | 179 | 0.100 |
Why?
|
| Sex Ratio | 1 | 2012 | 107 | 0.100 |
Why?
|
| Biomedical Research | 3 | 2013 | 3463 | 0.100 |
Why?
|
| Systems Integration | 2 | 2011 | 430 | 0.100 |
Why?
|
| Adult | 32 | 2016 | 223851 | 0.100 |
Why?
|
| Antibodies, Antinuclear | 1 | 2013 | 342 | 0.090 |
Why?
|
| Anxiety Disorders | 2 | 2013 | 2749 | 0.090 |
Why?
|
| Software | 4 | 2014 | 4479 | 0.090 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2014 | 491 | 0.090 |
Why?
|
| Sjogren's Syndrome | 1 | 2013 | 241 | 0.090 |
Why?
|
| Colorectal Neoplasms | 3 | 2016 | 6982 | 0.090 |
Why?
|
| Parturition | 1 | 2014 | 456 | 0.090 |
Why?
|
| New England | 4 | 2014 | 1058 | 0.090 |
Why?
|
| Logistic Models | 9 | 2015 | 13318 | 0.090 |
Why?
|
| Male | 39 | 2016 | 365203 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 643 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2019 | 2714 | 0.080 |
Why?
|
| Boston | 5 | 2016 | 9377 | 0.080 |
Why?
|
| Ethanol | 1 | 2016 | 1331 | 0.080 |
Why?
|
| Medical Informatics Applications | 1 | 2011 | 180 | 0.080 |
Why?
|
| Female | 42 | 2016 | 397515 | 0.080 |
Why?
|
| Hospital Shared Services | 1 | 2009 | 16 | 0.080 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 3730 | 0.080 |
Why?
|
| Limbic System | 1 | 2012 | 424 | 0.080 |
Why?
|
| Middle Aged | 29 | 2016 | 223737 | 0.080 |
Why?
|
| Humans | 55 | 2023 | 768970 | 0.080 |
Why?
|
| Immunologic Factors | 2 | 2015 | 1597 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2013 | 880 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2010 | 263 | 0.080 |
Why?
|
| Hypothyroidism | 1 | 2013 | 667 | 0.070 |
Why?
|
| Thromboembolism | 1 | 2014 | 1004 | 0.070 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 955 | 0.070 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2007 | 65 | 0.070 |
Why?
|
| Hospital Information Systems | 1 | 2009 | 394 | 0.070 |
Why?
|
| Risk Factors | 16 | 2016 | 74976 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5892 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2014 | 1080 | 0.070 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2007 | 166 | 0.070 |
Why?
|
| Autistic Disorder | 1 | 2016 | 1240 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2014 | 1410 | 0.070 |
Why?
|
| User-Computer Interface | 2 | 2010 | 1406 | 0.060 |
Why?
|
| Telemedicine | 1 | 2023 | 3110 | 0.060 |
Why?
|
| Medical Informatics | 1 | 2013 | 742 | 0.060 |
Why?
|
| Dyslipidemias | 1 | 2013 | 873 | 0.060 |
Why?
|
| Cesarean Section | 1 | 2014 | 1426 | 0.060 |
Why?
|
| Hydroxybutyrate Dehydrogenase | 2 | 1996 | 8 | 0.060 |
Why?
|
| ROC Curve | 3 | 2023 | 3629 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 2055 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2748 | 0.060 |
Why?
|
| Genome-Wide Association Study | 4 | 2014 | 12801 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 2008 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2014 | 3449 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2359 | 0.060 |
Why?
|
| Multivariate Analysis | 5 | 2015 | 12095 | 0.060 |
Why?
|
| Kidney | 4 | 1991 | 7058 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 1196 | 0.060 |
Why?
|
| Genotype | 6 | 2015 | 13048 | 0.050 |
Why?
|
| International Classification of Diseases | 3 | 2018 | 936 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7957 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 18068 | 0.050 |
Why?
|
| Case-Control Studies | 7 | 2014 | 22296 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2258 | 0.050 |
Why?
|
| Apolipoprotein E4 | 1 | 2007 | 712 | 0.050 |
Why?
|
| Young Adult | 8 | 2016 | 60131 | 0.050 |
Why?
|
| Risk Assessment | 5 | 2016 | 24333 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2276 | 0.050 |
Why?
|
| Lipids | 1 | 2013 | 3345 | 0.050 |
Why?
|
| Aldosterone | 3 | 1991 | 881 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3859 | 0.050 |
Why?
|
| Adolescent | 6 | 2016 | 89244 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 2517 | 0.050 |
Why?
|
| Health Services Research | 1 | 2009 | 1818 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2012 | 2426 | 0.050 |
Why?
|
| Time Factors | 4 | 2016 | 40261 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3253 | 0.050 |
Why?
|
| Comorbidity | 2 | 2013 | 10592 | 0.040 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 39394 | 0.040 |
Why?
|
| Bipolar Disorder | 2 | 2014 | 5131 | 0.040 |
Why?
|
| Sodium | 3 | 1982 | 1597 | 0.040 |
Why?
|
| Prognosis | 6 | 2016 | 30046 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2013 | 6413 | 0.040 |
Why?
|
| Diuresis | 2 | 1991 | 107 | 0.040 |
Why?
|
| Psychiatry | 1 | 2011 | 1716 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15951 | 0.040 |
Why?
|
| Aged | 14 | 2016 | 171786 | 0.040 |
Why?
|
| Prevalence | 2 | 2014 | 15879 | 0.040 |
Why?
|
| Incidence | 5 | 2014 | 21547 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3250 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2014 | 4850 | 0.040 |
Why?
|
| Models, Biological | 2 | 2013 | 9499 | 0.040 |
Why?
|
| Urine | 3 | 1991 | 362 | 0.040 |
Why?
|
| Risk | 3 | 2015 | 9621 | 0.030 |
Why?
|
| Genomics | 2 | 2011 | 5928 | 0.030 |
Why?
|
| Artificial Intelligence | 1 | 2011 | 2666 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2016 | 42683 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 790 | 0.030 |
Why?
|
| Registries | 1 | 2012 | 8384 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 20245 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 6569 | 0.030 |
Why?
|
| Mitochondria, Liver | 1 | 1996 | 190 | 0.030 |
Why?
|
| Blood Volume | 2 | 1991 | 546 | 0.030 |
Why?
|
| Unified Medical Language System | 1 | 2015 | 89 | 0.030 |
Why?
|
| Neoplasms | 2 | 2014 | 22389 | 0.030 |
Why?
|
| Nortriptyline | 1 | 2014 | 79 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 1996 | 406 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2014 | 112 | 0.030 |
Why?
|
| Rectal Fistula | 1 | 2014 | 76 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1645 | 0.030 |
Why?
|
| Genetic Research | 1 | 2014 | 173 | 0.030 |
Why?
|
| Research Design | 1 | 2009 | 6214 | 0.030 |
Why?
|
| United States | 7 | 2019 | 73186 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3985 | 0.030 |
Why?
|
| England | 1 | 2014 | 533 | 0.030 |
Why?
|
| Medical Audit | 1 | 2014 | 454 | 0.030 |
Why?
|
| Potassium | 2 | 1991 | 1315 | 0.030 |
Why?
|
| Saimiri | 2 | 1991 | 337 | 0.030 |
Why?
|
| Thyroiditis | 1 | 2013 | 86 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1991 | 657 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2015 | 9684 | 0.030 |
Why?
|
| Pregnancy | 6 | 2016 | 30265 | 0.030 |
Why?
|
| Bupropion | 1 | 2014 | 303 | 0.030 |
Why?
|
| Fornix, Brain | 1 | 2012 | 71 | 0.020 |
Why?
|
| Transglutaminases | 1 | 2013 | 200 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 26428 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 2 | 1991 | 326 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1498 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2013 | 405 | 0.020 |
Why?
|
| Citalopram | 1 | 2014 | 401 | 0.020 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 295 | 0.020 |
Why?
|
| Natriuresis | 1 | 1991 | 106 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2012 | 5323 | 0.020 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2011 | 105 | 0.020 |
Why?
|
| Sample Size | 1 | 2014 | 848 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 520 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2013 | 391 | 0.020 |
Why?
|
| Child | 3 | 2016 | 80960 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2019 | 2360 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1658 | 0.020 |
Why?
|
| Kinetics | 3 | 1996 | 6332 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2014 | 500 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 773 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15889 | 0.020 |
Why?
|
| Computer Systems | 1 | 2011 | 470 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 36556 | 0.020 |
Why?
|
| Causality | 1 | 2016 | 1256 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 937 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2014 | 584 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2012 | 677 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2013 | 947 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 12562 | 0.020 |
Why?
|
| Anisotropy | 1 | 2012 | 1295 | 0.020 |
Why?
|
| Methotrexate | 1 | 2015 | 1723 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3438 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 1418 | 0.020 |
Why?
|
| Electronics | 1 | 2009 | 317 | 0.020 |
Why?
|
| Pressure | 1 | 1991 | 1172 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 888 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 1987 | 125 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2013 | 26395 | 0.020 |
Why?
|
| Disease Progression | 2 | 2014 | 13674 | 0.020 |
Why?
|
| Kidney Medulla | 1 | 1987 | 169 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15471 | 0.020 |
Why?
|
| Colectomy | 1 | 2012 | 699 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1811 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 953 | 0.020 |
Why?
|
| Goals | 1 | 2011 | 717 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 2408 | 0.020 |
Why?
|
| Creatinine | 1 | 2012 | 1917 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 8094 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6320 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2012 | 1531 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Vasopressins | 1 | 1987 | 358 | 0.020 |
Why?
|
| Peptides | 1 | 2018 | 4353 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 27453 | 0.020 |
Why?
|
| Extremities | 1 | 1991 | 870 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 36854 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2014 | 81903 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1996 | 4213 | 0.010 |
Why?
|
| Alleles | 1 | 2015 | 6901 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6547 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2011 | 3626 | 0.010 |
Why?
|
| Rats | 5 | 1996 | 23786 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 16053 | 0.010 |
Why?
|
| Forecasting | 1 | 2011 | 2945 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 6030 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 54962 | 0.010 |
Why?
|
| Kidney Tubules, Distal | 1 | 1982 | 43 | 0.010 |
Why?
|
| Research | 1 | 2010 | 1981 | 0.010 |
Why?
|
| Massachusetts | 1 | 2014 | 8894 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2014 | 6291 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2015 | 6611 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2014 | 3313 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2011 | 2784 | 0.010 |
Why?
|
| Urodynamics | 1 | 1982 | 349 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2012 | 65480 | 0.010 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1982 | 385 | 0.010 |
Why?
|
| Survival Rate | 1 | 2014 | 12873 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14752 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3580 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 4168 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8748 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10633 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 2784 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 1996 | 3588 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1981 | 557 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 59739 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 3538 | 0.010 |
Why?
|
| Spironolactone | 1 | 1981 | 415 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2014 | 13055 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 174 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 9080 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 14794 | 0.010 |
Why?
|
| Animals | 7 | 1996 | 169335 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 7148 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1996 | 694 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1731 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 1993 | 72 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 1993 | 76 | 0.010 |
Why?
|
| Depression | 1 | 2013 | 8231 | 0.010 |
Why?
|
| Liposomes | 1 | 1996 | 793 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 1229 | 0.010 |
Why?
|
| Asthma | 1 | 2009 | 6293 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1993 | 1990 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1980 | 4199 | 0.010 |
Why?
|
| Phospholipids | 1 | 1993 | 787 | 0.010 |
Why?
|
| NAD | 1 | 1993 | 618 | 0.010 |
Why?
|
| Homeostasis | 1 | 1980 | 3347 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 3956 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15661 | 0.000 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 1987 | 87 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 6512 | 0.000 |
Why?
|
| Tyrosine | 1 | 1987 | 1427 | 0.000 |
Why?
|
| Gene Expression | 1 | 1993 | 7603 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1980 | 565 | 0.000 |
Why?
|
| Kidney Tubules | 1 | 1980 | 454 | 0.000 |
Why?
|
| Liver | 1 | 1993 | 7578 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1980 | 1500 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1980 | 2228 | 0.000 |
Why?
|